Two systematic reviews revealed very low-certainty evidence on outcomes for people with gender dysphoria
Findings seen among adolescent and young adult Medicaid enrollees
Drug is the first and only approved monotherapy for refractory major depressive disorder
Antimicrobials, vaccines, anti-inflammatories linked to reduced risk for Alzheimer disease and dementia; antipsychotics and diabetes drugs tied to higher risk
Those who chose to receive MOUD plus app-based CM reported significantly fewer days of opioid use at end of treatment
Findings seen in patients following myocardial infarction
More than three-quarters of prescriptions were for a supply of more than seven days; 55 percent for 15 to 30 days
Of the about one-third receiving stimulant medication, 71.5 percent had difficulty filling prescription due to unavailability
Higher annual health care expenditures and lower quality of life reported for individuals with rheumatoid arthritis